GB0517175D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0517175D0 GB0517175D0 GBGB0517175.6A GB0517175A GB0517175D0 GB 0517175 D0 GB0517175 D0 GB 0517175D0 GB 0517175 A GB0517175 A GB 0517175A GB 0517175 D0 GB0517175 D0 GB 0517175D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- 6alkyl
- haloc1
- hydrogen
- 6alkoxy
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517175.6A GB0517175D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
EP06791595A EP1917242B1 (en) | 2005-08-22 | 2006-08-18 | Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
DE602006004882T DE602006004882D1 (de) | 2005-08-22 | 2006-08-18 | Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren |
ES06791595T ES2320699T3 (es) | 2005-08-22 | 2006-08-18 | Derivados de azabiciclo(3.1.0)hexilfelino como moduladores de receptores d3 de dopamina. |
JP2008527372A JP5084731B2 (ja) | 2005-08-22 | 2006-08-18 | ドーパミンd3受容体の調節因子としてのアザビシクロ[3.1.0]ヘキシルフェニル誘導体 |
US12/064,121 US7776904B2 (en) | 2005-08-22 | 2006-08-18 | Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors |
AT06791595T ATE420859T1 (de) | 2005-08-22 | 2006-08-18 | Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren |
PCT/EP2006/008202 WO2007022935A1 (en) | 2005-08-22 | 2006-08-18 | Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine d3 receptors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517175.6A GB0517175D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0517175D0 true GB0517175D0 (en) | 2005-09-28 |
Family
ID=35098086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0517175.6A Ceased GB0517175D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
Country Status (8)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1745040E (pt) * | 2004-02-23 | 2010-03-08 | Glaxo Group Ltd | Derivados do azabiciclo3.1.0-hexano úteis como moduladores dos receptores d3 da dopamina |
GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507601D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
WO2006133945A1 (en) * | 2005-06-14 | 2006-12-21 | Glaxo Group Limited | Novel compounds |
GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
PL2719384T3 (pl) | 2005-07-27 | 2019-02-28 | Otsuka America Pharmaceutical, Inc. | Nowe 1-naftylo-3-azabicyklo[3.1.0]heksany: wytwarzanie i zastosowanie do leczenia zaburzeń neuropsychiatrycznych |
GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
EP1919908B1 (en) * | 2005-08-22 | 2010-11-10 | Glaxo Group Limited | Triazole derivatives as modulators of dopamine d3 receptors |
GB0517193D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
EP2010518B1 (en) * | 2006-04-03 | 2011-02-16 | Glaxo Group Limited | Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
EP2007751B1 (en) * | 2006-04-03 | 2013-08-21 | Glaxo Group Limited | Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
MX2012000231A (es) | 2009-06-26 | 2012-03-07 | Panacea Biotec Ltd | Nuevos aza-biciclo-hexanos. |
US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
TWI712598B (zh) | 2016-07-20 | 2020-12-11 | 瑞士商諾華公司 | 胺基吡啶衍生物及其作為選擇性alk-2抑制劑之用途 |
CN108997177A (zh) * | 2018-09-04 | 2018-12-14 | 邵阳学院 | 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL65843A (en) * | 1977-08-11 | 1986-12-31 | American Cyanamid Co | Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US6204284B1 (en) | 1991-12-20 | 2001-03-20 | American Cyanamid Company | Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies |
PT1745040E (pt) | 2004-02-23 | 2010-03-08 | Glaxo Group Ltd | Derivados do azabiciclo3.1.0-hexano úteis como moduladores dos receptores d3 da dopamina |
GB0507602D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507601D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507680D0 (en) | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
WO2006133945A1 (en) | 2005-06-14 | 2006-12-21 | Glaxo Group Limited | Novel compounds |
JP2009502798A (ja) * | 2005-07-21 | 2009-01-29 | ワイス | 神経系障害および状態の処置方法 |
GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
EP1919908B1 (en) | 2005-08-22 | 2010-11-10 | Glaxo Group Limited | Triazole derivatives as modulators of dopamine d3 receptors |
GB0517193D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
GB0517187D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
WO2007113232A1 (en) | 2006-04-03 | 2007-10-11 | Glaxo Group Limited | Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
GB0616574D0 (en) | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
DE102006035468A1 (de) * | 2006-11-29 | 2008-06-05 | Dilo Trading Ag | Modifizierte Elektroden für elektrische Energiespeicher |
-
2005
- 2005-08-22 GB GBGB0517175.6A patent/GB0517175D0/en not_active Ceased
-
2006
- 2006-08-18 EP EP06791595A patent/EP1917242B1/en active Active
- 2006-08-18 DE DE602006004882T patent/DE602006004882D1/de active Active
- 2006-08-18 AT AT06791595T patent/ATE420859T1/de not_active IP Right Cessation
- 2006-08-18 ES ES06791595T patent/ES2320699T3/es active Active
- 2006-08-18 WO PCT/EP2006/008202 patent/WO2007022935A1/en active Application Filing
- 2006-08-18 JP JP2008527372A patent/JP5084731B2/ja not_active Expired - Fee Related
- 2006-08-18 US US12/064,121 patent/US7776904B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090030062A1 (en) | 2009-01-29 |
ES2320699T3 (es) | 2009-05-27 |
US7776904B2 (en) | 2010-08-17 |
JP2009504793A (ja) | 2009-02-05 |
DE602006004882D1 (de) | 2009-03-05 |
ATE420859T1 (de) | 2009-01-15 |
EP1917242A1 (en) | 2008-05-07 |
EP1917242B1 (en) | 2009-01-14 |
JP5084731B2 (ja) | 2012-11-28 |
WO2007022935A1 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0517175D0 (en) | Compounds | |
GB0517191D0 (en) | Compounds | |
EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
JO2686B1 (en) | Vehicles | |
BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
EA200801011A1 (ru) | Производные пиразина как модуляторы натриевых каналов для лечения боли | |
RS20080119A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
BRPI0409109A (pt) | novos compostos | |
EA200700099A1 (ru) | Производные пиридина | |
TW200716529A (en) | New compounds II | |
WO2009069032A3 (en) | Novel glucocorticoid receptor agonists | |
MY145613A (en) | Novel compounds | |
MX2009011816A (es) | Derivados de piridina. | |
EA200702200A1 (ru) | Дигидротиенопиримидины для лечения воспалительных заболеваний | |
TW200745122A (en) | New compounds I | |
TW200833670A (en) | Novel compounds 569 | |
GB0507601D0 (en) | Compounds | |
TW200639156A (en) | New compounds | |
MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
MX2007003119A (es) | Nuevas amidas heterociclicas. | |
MX2011012669A (es) | Nuevos agonistas del receptor de glucocorticoides. | |
TW200730512A (en) | Novel compounds | |
TW200720262A (en) | Novel compounds ii | |
MY158069A (en) | Tricyclic compound and pharmaceutical use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |